|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2011-2-9
|
|
pubmed:abstractText |
Dogs with multicentric T-cell lymphoma are commonly treated with CHOP chemotherapy protocols that include cyclophosphamide, doxorubicin, vincristine and prednisone. The purpose of this study was to evaluate the use of CHOP chemotherapy for dogs with multicentric T-cell lymphoma. Identification of prognostic factors in this specific subset of dogs was of secondary interest. Twenty-three out of 24 dogs responded to CHOP chemotherapy and these dogs remained on the protocol for a median of 146 days. No variable was associated with progression free survival (PFS) including stage, substage, hypercalcemia or radiographic evidence of a cranial mediastinal mass. The median overall survival time (OST) for all dogs was 235 days. Dogs that were thrombocytopenic at presentation experienced a significantly longer OST (323 versus 212 days, P=0.01).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1476-5829
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
© 2010 Blackwell Publishing Ltd.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
9
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
38-44
|
|
pubmed:meshHeading |
pubmed-meshheading:21303452-Animals,
pubmed-meshheading:21303452-Antineoplastic Agents,
pubmed-meshheading:21303452-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:21303452-California,
pubmed-meshheading:21303452-Cyclophosphamide,
pubmed-meshheading:21303452-Disease-Free Survival,
pubmed-meshheading:21303452-Dog Diseases,
pubmed-meshheading:21303452-Dogs,
pubmed-meshheading:21303452-Doxorubicin,
pubmed-meshheading:21303452-Female,
pubmed-meshheading:21303452-Lymphoma, T-Cell,
pubmed-meshheading:21303452-Male,
pubmed-meshheading:21303452-Neoplasm Staging,
pubmed-meshheading:21303452-Prednisone,
pubmed-meshheading:21303452-Prognosis,
pubmed-meshheading:21303452-Retrospective Studies,
pubmed-meshheading:21303452-Vincristine
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
CHOP chemotherapy for the treatment of canine multicentric T-cell lymphoma.
|
|
pubmed:affiliation |
Department of Surgical and Radiological Sciences, One Shields Avenue, University of California, Davis, CA 95616, USA. rbrebhun@ucdavis.edu
|
|
pubmed:publicationType |
Journal Article
|
